TITLE

Serum lemur tyrosine kinase 3 expression in colorectal cancer patients predicts cancer progression and prognosis

AUTHOR(S)
Shi, Hongbing; Wu, Jun; Ji, Mei; Zhou, Qi; Li, Zhengguang; Zheng, Xiao; Xu, Bing; Deng, Haifeng; Zhao, Weiqing; Wu, Changping; Jiang, Jingting
PUB. DATE
December 2013
SOURCE
Medical Oncology;Dec2013, Vol. 30 Issue 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
92576978

 

Related Articles

  • Preoperative serum LMTK3 as a novel biomarker in non-small cell lung cancer. Xu, Zhaoguo; Qi, Xiaoying; Zhang, Xiaoye; Yu, Li // Tumor Biology;May2014, Vol. 35 Issue 5, p5007 

    The lemur tyrosine kinase-3 (LMTK3) has been reported to be involved in tumor progression. The aim of this study was to determine the diagnostic and prognostic significances of preoperative serum LMTK3 in non-small cell lung cancer (NSCLC) patients. Sera were collected from 100 healthy...

  • High Expression of LMTK3 is an Independent Factor Indicating a Poor Prognosis in Estrogen Receptor α-Positive Breast Cancer Patients. Asano, Tomoko; Sato, Shinya; Yoshimoto, Nobuyasu; Endo, Yumi; Hato, Yukari; Dong, Yu; Takahashi, Satoru; Fujii, Yoshitaka; Toyama, Tatsuya // Japanese Journal of Clinical Oncology;Oct2014, Vol. 44 Issue 10, p889 

    Objective Over 70% of breast cancers are estrogen receptor alpha-positive, and endocrine therapy targeting estrogen action decreases mortality from breast cancer. Recently, a novel protein kinase that regulates estrogen receptor alpha activity, lemur tyrosine kinase-3, has been identified. In...

  • Ciblage du récepteur aux facteurs de croissance épithéliaux (REGF) par les inhibiteurs de tyrosine kinase et applications dans les cancers colorectaux. Magné, N.; Toillon, R.-A. // Oncologie;fev2004, Vol. 6 Issue 1, p41 

    EGF receptor is moderately overexpressed in colorectal cancer and it is globally associated to poor prognosis outcome. Thus determination of EGFR level represents a major interest in order to orientate a targeted therapy and to redefine a new prognostic biological marker to treat colorectal...

  • Increased Serum Concentration of Circulating Soluble Receptor for Interleukin-2 and Its Effect as a Prognostic Indicator in Cachectic Patients with Gastric and Colorectal Cancer. Shibata, Masahiko; Takekawa, Motoo // Oncology;1999, Vol. 56 Issue 1, p54 

    Serum concentration of soluble interleukin-2 receptor (sIL-2R) was measured in noncachectic patients with 42 gastric and 32 colorectal cancers, 39 cachectic cancer patients and 15 normal volunteers. It increased with the advance of cancer, being highest in the cachectic patients. It was...

  • RON is not a prognostic marker for resectable pancreatic cancer. Tactacan, Carole M.; Chang, David K.; Cowley, Mark J.; Humphrey, Emily S.; Wu, Jianmin; Gill, Anthony J.; Chou, Angela; Nones, Katia; Grimmond, Sean M.; Sutherland, Robert L.; Biankin, Andrew V.; Daly, Roger J. // BMC Cancer;2012, Vol. 12 Issue 1, p395 

    Background: The receptor tyrosine kinase RON exhibits increased expression during pancreatic cancer progression and promotes migration, invasion and gemcitabine resistance of pancreatic cancer cells in experimental models. However, the prognostic significance of RON expression in pancreatic...

  • For Advanced GIST, Regorafenib Shows Robust Effect.  // American Health & Drug Benefits;August Special Issue 2012, Vol. 5, p11 

    The article discusses a 2012 meeting of the American Society of Clinical Oncology in Chicago, Illinois, focusing on the comments of the researcher George D. Demetri concerning the potential impact of the orally administered tyrosine kinase inhibitor in delaying the disease progression of...

  • Kolorektal kanserde anjiyogenez ve anti-anjiyogenik tedaviler. AKTAŞ, Sedef Hande; AKBULUT, Hakan // Turkish Journal of Oncology / Türk Onkoloji Dergisi;2014, Vol. 29 Issue 2, p67 

    Angiogenesis is extremely important in cancer progression. The therapeutic approaches that target regression of tumors through suppression of angiogenesis have been under investigation for a long time. In addition to chemotherapy, monotherapy as well as monoclonal antibodies and tyrosine kinase...

  • Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer. Chen, Wei-Ching; Wang, Chih-Yang; Hung, Yu-Hsuan; Weng, Tzu-Yang; Yen, Meng-Chi; Lai, Ming-Derg // PLoS ONE;5/12/2016, Vol. 11 Issue 5, p1 

    Dysregulated lipid metabolism contributes to cancer progression. Our previous study indicates that long-chain fatty acyl-Co A synthetase (ACSL) 3 is essential for lipid upregulation induced by endoplasmic reticulum stress. In this report, we aimed to identify the role of ACSL family in cancer...

  • P53 expression may correlate with bladder cancer prognosis. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;09/25/97, Vol. 10 Issue 9, p30 

    Focuses on a study of patients with muscle-invasive bladder cancer. Prognosis of patients where p53 protein was not expressed; Correlation of p53 expression with bladder cancer progression; Comparison with cancer staging and grading; Predictive value of p53 expression.

  • Assessing the role of the EGF receptor in the development and progression of pancreatic cancer. Cook, Natalie; Frese, Kristopher K.; Moore, Malcolm // Gastrointestinal Cancer: Targets & Therapy;2014, Vol. 4, p23 

    The prognosis for patients with pancreatic cancer remains poor despite increased knowledge of its molecular genetics and histopathological progression. Pancreatic cancer is a complicated, heterogeneous tumor with several common genetic alterations. Aberrant epidermal growth factor receptor...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics